Pfizer Halts Sales of Exubera In Wake of Lung Cancer Fears
April 16th, 2008
In wake of news that its inhaled insulin product Exubera has been linked to lung cancer, Pfizer Inc. has announced that it will cease manufacturing the drug and update labels on the remaining product to carry a cancer warning.